2D QSAR studies of the inhibitory activity of a series of substituted purine derivatives against c-Src tyrosine kinase

Ullrich A., 1990, Cell, 61, 203, 10.1016/0092-8674(90)90801-K Thomas S.M., 1997, Annu. Rev. Cell Dev. Biol., 13, 513, 10.1146/annurev.cellbio.13.1.513 Yu X.M., 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 7697, 10.1073/pnas.96.14.7697 Russello S.V., 2004, Front. Biosci., 9, 139 Tsygankov A.Y., 2004, Curr. Pharm. Des., 10, 1745, 10.2174/1381612043384457 Hunter T., 2000, Cell, 100, 113, 10.1016/S0092-8674(00)81688-8 DeMali K.A., 1999, Exp. Cell. Res., 253, 271, 10.1006/excr.1999.4669 Al-Obeidi F.A., 1998, Biopolymers, 47, 197, 10.1002/(SICI)1097-0282(1998)47:3<197::AID-BIP2>3.0.CO;2-H Roskoski R., 2005, Biochem. Biophys. Res. Commun., 331, 1, 10.1016/j.bbrc.2005.03.012 10.1517/13543776.15.9.1183 Irby R.B., 2000, Oncogene, 19, 5636, 10.1038/sj.onc.1203912 Kurup A., 2001, Chem. Rev., 101, 2727, 10.1021/cr000025g Tintori C., 2009, Eur. J. Med. Chem., 44, 990, 10.1016/j.ejmech.2008.07.002 Bairy S.K., 2009, Chem. Biol. Drug Des., 73, 416, 10.1111/j.1747-0285.2009.00789.x Cao R., 2010, J. Mol. Model., 16, 361, 10.1007/s00894-009-0530-1 Cao H., 2007, J. Mol. Graph. Model., 26, 236, 10.1016/j.jmgm.2006.12.001 VLife MDS Software Package, Version 3.52008Supplied by VLife Science Technologies Pvt. Ltd.Pune Huang H., 2010, Bioorg. Med. Chem., 18, 4615, 10.1016/j.bmc.2010.05.032 Golbraikh A., 2002, J. Comput. Aided Mol. Des., 16, 357, 10.1023/A:1020869118689 Halgren T.A., 1996, J. Comput. Chem., 17, 553, 10.1002/(SICI)1096-987X(199604)17:5/6<553::AID-JCC3>3.0.CO;2-T Cramer R.D., 1988, Quant. Struct. Act. Relat., 7, 18, 10.1002/qsar.19880070105